Let’s discuss four foods to avoid with psoriasis that may be affecting your skin, along with healthier substitutes.

Accropeutics’ oral, selective TYK2/JAK1 inhibitor AC-201 has met the primary and key secondary endpoints in a Phase II ...

Treatment with guselkumab among patients with psoriasis does not contribute to the risk for or progression of liver fibrosis.

For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers ...

Skin symptoms may clear with biologics in psoriasis, but hidden internal inflammation often persists, contributing to major ...

Roivant has its own TYK2/JAK1 inhibitor in development in the form of brepocitinib, which the biopharma licensed from Pfizer ...

A new study reveals psoriasis may increase the risk of obesity and fatty liver despite skin improvements Learn why managing inflammation beyond the skin is essential ...

A new study published in the journal of Acta Dermato Venerologica showed that menopause might have neutral to negative impact ...

For patients with genital psoriasis, apremilast improved genital Physician Global Assessment scores, itch, and quality of life with a tolerable safety profile.

Learn why blue light can have negative, and sometimes positive, impacts on our health, and what to do to combat it.

Psoriasis, with its systemic inflammatory nature, high risk of cardiovascular disease, and frequent use of biologic drugs, ...

MEDIA RELEASE Pyzchiva® first ustekinumab biosimilar in Europe commercially available in pre-filled pen (autoinjector), offering improved self-administration experience for better treatment adherence ...